David W. Russell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
David W. Russell has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
Pei-Rong Wang
6 shared publicationsRoli K Hirata
Department of Medicine, University of Washington, Seattle, Washington, USA
6 shared publicationsYi Li
6 shared publicationsDavid R Deyle
Department of Medicine, University of Washington, Seattle, Washington, USA
4 shared publicationsGrant D. Trobridge
Division of Hematology, University of Washington, Seattle, WA
4 shared publicationsIram F Khan
Department of Medicine, University of Washington, Seattle, Washington, USA
4 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 15 May 2017
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (8) , 765-772
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Expression of the minimally polymorphic HLA-E molecule prevents NK-cell-mediated rejection of cells lacking expression of HLA-A, B and C. Polymorphisms in the human leukocyte antigen (HLA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogeneic recipients. Disruption of the Beta-2 Microglobulin (B2M) gene eliminates surface expression of all class I molecules, but leaves the cells vulnerable to lysis by natural killer (NK) cells. Here we show that this 'missing-self' response can be prevented by forced expression of minimally polymorphic HLA-E molecules. We use adeno-associated virus (AAV)-mediated gene editing to knock in HLA-E genes at the B2M locus in human PSCs in a manner that confers inducible, regulated, surface expression of HLA-E single-chain dimers (fused to B2M) or trimers (fused to B2M and a peptide antigen), without surface expression of HLA-A, B or C. These HLA-engineered PSCs and their differentiated derivatives are not recognized as allogeneic by CD8+ T cells, do not bind anti-HLA antibodies and are resistant to NK-mediated lysis. Our approach provides a potential source of universal donor cells for applications where the differentiated derivatives lack HLA class II expression.
- 15 May 2017
- Published by Springer Nature in Nature Biotechnology
- Vol. 35 (8) , 765-772
Top Cited PapersOpen AccessHLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Expression of the minimally polymorphic HLA-E molecule prevents NK-cell-mediated rejection of cells lacking expression of HLA-A, B and C. Polymorphisms in the human leukocyte antigen (HLA) class I genes can cause the rejection of pluripotent stem cell (PSC)-derived products in allogeneic recipients. Disruption of the Beta-2 Microglobulin (B2M) gene eliminates surface expression of all class I molecules, but leaves the cells vulnerable to lysis by natural killer (NK) cells. Here we show that this 'missing-self' response can be prevented by forced expression of minimally polymorphic HLA-E molecules. We use adeno-associated virus (AAV)-mediated gene editing to knock in HLA-E genes at the B2M locus in human PSCs in a manner that confers inducible, regulated, surface expression of HLA-E single-chain dimers (fused to B2M) or trimers (fused to B2M and a peptide antigen), without surface expression of HLA-A, B or C. These HLA-engineered PSCs and their differentiated derivatives are not recognized as allogeneic by CD8+ T cells, do not bind anti-HLA antibodies and are resistant to NK-mediated lysis. Our approach provides a potential source of universal donor cells for applications where the differentiated derivatives lack HLA class II expression.
- Open Access
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S114-S115
285. Foamy Viral Vector Expressing Human CD18 Results in High Levels of Transduction and Multilineage Engraftment with CD18+ LAD-1 Cells in NSG Mice
- 1 May 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24, S114-S115
Open Access285. Foamy Viral Vector Expressing Human CD18 Results in High Levels of Transduction and Multilineage Engraftment with CD18+ LAD-1 Cells in NSG Mice
- Open Access
- 1 March 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (3) , 582-591
Silent IL2RG Gene Editing in Human Pluripotent Stem Cells
- 1 March 2016
- Published by Elsevier in Molecular Therapy
- Vol. 24 (3) , 582-591
Open AccessSilent IL2RG Gene Editing in Human Pluripotent Stem Cells
- Open Access
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S98
250. The Cellular Origins of Regenerating Nodules and Malignant Formation in the FAH Model of Liver Injury After Bone Marrow Transplantation
- 1 May 2015
- Published by Elsevier in Molecular Therapy
- Vol. 23, S98
Open Access250. The Cellular Origins of Regenerating Nodules and Malignant Formation in the FAH Model of Liver Injury After Bone Marrow Transplantation
- Open Access
- 5 October 2014
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 21 (11) , 969-975
A genome-wide map of adeno-associated virus–mediated human gene targeting
A genome-wide screen of gene targeting by an adeno-associated virus vector in human cells reveals that target sites are preferentially located where transcription occurs in the opposite direction from DNA replication, suggesting that colliding polymerases promote homologous recombination. To determine which genomic features promote homologous recombination, we created a genome-wide map of gene targeting sites. We used an adeno-associated virus vector to target identical loci introduced as transcriptionally active retroviral vectors. A comparison of ~2,000 targeted and untargeted sites showed that targeting occurred throughout the human genome and was not influenced by the presence of nearby CpG islands, sequence repeats or DNase I–hypersensitive sites. Targeted sites were preferentially located within transcription units, especially when the target loci were transcribed in the opposite orientation to their surrounding chromosomal genes. We determined the impact of DNA replication by mapping replication forks, which revealed a preference for recombination at target loci transcribed toward an incoming fork. Our results constitute the first genome-wide screen of gene targeting in mammalian cells and demonstrate a strong recombinogenic effect of colliding polymerases.
- 5 October 2014
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 21 (11) , 969-975
Open AccessA genome-wide map of adeno-associated virus–mediated human gene targeting
A genome-wide screen of gene targeting by an adeno-associated virus vector in human cells reveals that target sites are preferentially located where transcription occurs in the opposite direction from DNA replication, suggesting that colliding polymerases promote homologous recombination. To determine which genomic features promote homologous recombination, we created a genome-wide map of gene targeting sites. We used an adeno-associated virus vector to target identical loci introduced as transcriptionally active retroviral vectors. A comparison of ~2,000 targeted and untargeted sites showed that targeting occurred throughout the human genome and was not influenced by the presence of nearby CpG islands, sequence repeats or DNase I–hypersensitive sites. Targeted sites were preferentially located within transcription units, especially when the target loci were transcribed in the opposite orientation to their surrounding chromosomal genes. We determined the impact of DNA replication by mapping replication forks, which revealed a preference for recombination at target loci transcribed toward an incoming fork. Our results constitute the first genome-wide screen of gene targeting in mammalian cells and demonstrate a strong recombinogenic effect of colliding polymerases.
- Open Access
- 25 December 2013
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (5) , 3119-3124
The effects of polymorphisms on human gene targeting
DNA mismatches that occur between vector homology arms and chromosomal target sequences reduce gene targeting frequencies in several species; however, this has not been reported in human cells. Here we demonstrate that even a single mismatched base pair can significantly decrease human gene targeting frequencies. In addition, we show that homology arm polymorphisms can be used to direct allele-specific targeting or to improve unfavorable vector designs that introduce deletions.
- 25 December 2013
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 42 (5) , 3119-3124
Open AccessThe effects of polymorphisms on human gene targeting
DNA mismatches that occur between vector homology arms and chromosomal target sequences reduce gene targeting frequencies in several species; however, this has not been reported in human cells. Here we demonstrate that even a single mismatched base pair can significantly decrease human gene targeting frequencies. In addition, we show that homology arm polymorphisms can be used to direct allele-specific targeting or to improve unfavorable vector designs that introduce deletions.
- Open Access
- 1 June 2013
- Published by Elsevier in Molecular Therapy
- Vol. 21 (6) , 1232-1241
HLA Engineering of Human Pluripotent Stem Cells
- 1 June 2013
- Published by Elsevier in Molecular Therapy
- Vol. 21 (6) , 1232-1241
Open AccessHLA Engineering of Human Pluripotent Stem Cells
- Open Access
- 7 February 2013
- Published by Springer Nature in Gene Therapy
- Vol. 20 (8) , 868-873
Lack of genotoxicity due to foamy virus vector integration in human iPSCs
Integrating vectors can lead to the dysregulation of nearby chromosomal genes, with important consequences for clinical trials and cellular engineering. This includes the retroviral and lentiviral vectors commonly used for deriving induced pluripotent stem cells (iPSCs). We previously used integrating foamy virus (FV) vectors expressing OCT4, SOX2, MYC and KLF4 to reprogram osteogenesis imperfecta mesenchymal stem cells (MSCs). Here, we have studied the effects of 10 FV vector proviruses on neighboring gene expression in four iPSC lines and their corresponding iPSC-derived MSC (iMSCs). Gene expression profiles in these iPSC lines showed that none of the 38 genes within 300 kb up- or downstream of integrated proviruses had a significant difference in mRNA levels, including five genes with proviruses in their transcription units. In the iMSCs derived from these iPSCs, the same type of analysis showed a single dysregulated transcript out of 46 genes found near proviruses. This frequency of dysregulation was similar to that of genes lacking nearby proviruses, so it may have been due to interclonal variation and/or measurement inaccuracies. While the number of integration sites examined in this paper is limited, our results suggest that integrated FV proviruses do not impact the expression of chromosomal genes in pluripotent human stem cells or their differentiated derivatives. This interpretation is consistent with previous reports that FV vectors have minimal genotoxicity, even when integrating near or within genes.
- 7 February 2013
- Published by Springer Nature in Gene Therapy
- Vol. 20 (8) , 868-873
Open AccessLack of genotoxicity due to foamy virus vector integration in human iPSCs
Integrating vectors can lead to the dysregulation of nearby chromosomal genes, with important consequences for clinical trials and cellular engineering. This includes the retroviral and lentiviral vectors commonly used for deriving induced pluripotent stem cells (iPSCs). We previously used integrating foamy virus (FV) vectors expressing OCT4, SOX2, MYC and KLF4 to reprogram osteogenesis imperfecta mesenchymal stem cells (MSCs). Here, we have studied the effects of 10 FV vector proviruses on neighboring gene expression in four iPSC lines and their corresponding iPSC-derived MSC (iMSCs). Gene expression profiles in these iPSC lines showed that none of the 38 genes within 300 kb up- or downstream of integrated proviruses had a significant difference in mRNA levels, including five genes with proviruses in their transcription units. In the iMSCs derived from these iPSCs, the same type of analysis showed a single dysregulated transcript out of 46 genes found near proviruses. This frequency of dysregulation was similar to that of genes lacking nearby proviruses, so it may have been due to interclonal variation and/or measurement inaccuracies. While the number of integration sites examined in this paper is limited, our results suggest that integrated FV proviruses do not impact the expression of chromosomal genes in pluripotent human stem cells or their differentiated derivatives. This interpretation is consistent with previous reports that FV vectors have minimal genotoxicity, even when integrating near or within genes.
- 1 November 2012
- Published by Elsevier in Cell Stem Cell
- Vol. 11 (5) , 615-619
Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells
- 1 November 2012
- Published by Elsevier in Cell Stem Cell
- Vol. 11 (5) , 615-619
Trisomy Correction in Down Syndrome Induced Pluripotent Stem Cells
- Open Access
- 1 October 2012
- Published by Elsevier in Molecular Therapy
- Vol. 20 (10) , 1842-1843
AAV Vectors for the Nucleolus
- 1 October 2012
- Published by Elsevier in Molecular Therapy
- Vol. 20 (10) , 1842-1843
Open AccessAAV Vectors for the Nucleolus